Third-generation anti-CD19 CAR T-cells show efficacy without

Third-generation anti-CD19 CAR T-cells show efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial

Third-generation anti-CD19 CAR T-cells show efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial

medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Guangzhou , Guangdong , China , New Zealand , United States , San Diego , California , Zhaotai , Gansu , American , Robert Weinkove , Peter Lai , Malaghan Institute Of Medical Research , Malaghan Institute Of Medical Research How , Wellington Zhaotai Therapies , Malaghan Institute , Hunan Zhaotai Medical Group , Wellington Zhaotai Therapies Limited Executive Director , Guangzhou Institute Of Biomedicine , American Society Of Hematology , Malaghan Institute Clinical , Medical Research , Wellington Zhaotai Therapies Limited , American Society , Annual Meeting , Malaghan Institute Clinical Director , Principal Investigator , Guangzhou Institute , Hunan Zhaotai Medical , Wellington Zhaotai Therapies Limited Executive , Professor Carl June , Escalation Trial , Toll Like Receptor , Intracellular Domains , Refractoryb Cell Non Hodgkin Lymphomas ,